Cerebral Cortex 1991; 1:103-116
© Oxford University Press 1991
research-article |
The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease
1Departments of Neurology Iowa City, Iowa 52242, 2Anatomy University of Iowa College of Medicine Iowa City, Iowa 52242
Correspondence should be addressed to Dr. Gary W. Van Hoesen, Department of Anatomy, Bowen Science Building, University of Iowa, Iowa City, IA 52242.
The distribution of neurofibrillary tangles (NFTs) and neuritic plaques (NPs) was mapped in 39 cortical areas of 11 brains of patients with Alzheimer's disease (AD). Whole hemisphere blocks were embedded in polyethylene glycol (Carbowax), sectioned coronally, and stained with thioflavin S and thionin. The densities of NFTs and NPs were assessed using a numerical rating scale for each area. Scores were grouped by type of cortex and by lobe for statistical analysis. Highly significant differences were ohtained. For example, limbic periallocor tex and allocortex had more NFTs than any other type of cortex. In descending order, the density of NFTs was as follows: penallocortex (area 28) > allocortex (suhiculum/CA1 zones of hippocampal formation, area 51) > corticoid areas (accessory basal nucleus of amygdala, nucleus hasalis of Meynert) > proisocortex (areas 11, 12, 24, 23, anterior insula, 38, 35) > nonprimary association cortex (32, 46, superior temporal sulcus, 40, 39, posterior parahippocampal cortex, 37, 36) > pri mary sensory association cortex (7, 18, 19, 22, 21, 20) > agranular cortex (445, 8, 6, 4) > primary sensory cortex (412, 312, 17). The laminar distribution of NFTs tended to be selective, involving primarily layers III and V of association areas and layers II and IV of limbic periallocortex. There were far more NFTs in both limbic and temporal lobes than in frontal, panetal, and occipital lobes. In general, NPs were more evenly dis tributed throughout the cortex, with the exceptions of limbic periallocortex and allocortex, which had notably fewer NPs than other cortical areas. Temporal and oc cipital lobes had the highest NP densities, limbic and frontal lobes had the lowest, and panetal lobe was intermediate. No significant left-right hemispheric dif ferences for NFT or NP densities were found across the population, and there was no relationship between du ration of illness and densities of NFTs or NPs.
The regional and laminar distribution of NFTs (and, to a lesser degree, that of NPs) suggests a consistent pattern of vulnerability within the cerebral cortices that seems correlated to the hierarchies of cortico-cortical connections. The higher-order association cortices, es pecially those in the anterior and ventromedial sectors of temporal lobe, are the most vulnerable, while other cortices appear less vulnerable to a degree commen surate with their connectional "distance" (i.e., synapses removed) from the limbic areas.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
W. E. Klunk Biopsy Support for the Validity of Pittsburgh Compound B Positron Emission Tomography With a Twist Arch Neurol, October 1, 2008; 65(10): 1281 - 1283. [Full Text] [PDF] |
||||
![]() |
B. C. Dickerson, A. Bakkour, D. H. Salat, E. Feczko, J. Pacheco, D. N. Greve, F. Grodstein, C. I. Wright, D. Blacker, H. D. Rosas, et al. The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals Cereb Cortex, July 16, 2008; (2008) bhn113v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Jalbert, L. A. Daiello, and K. L. Lapane Dementia of the Alzheimer Type Epidemiol. Rev., July 16, 2008; (2008) mxn008v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mapstone, K. Dickerson, and C. J. Duffy Distinct mechanisms of impairment in cognitive ageing and Alzheimer's disease Brain, June 1, 2008; 131(6): 1618 - 1629. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wiederkehr, M. Simard, C. Fortin, and R. van Reekum Comparability of the Clinical Diagnostic Criteria for Vascular Dementia: A Critical Review. Part I J Neuropsychiatry Clin Neurosci, May 1, 2008; 20(2): 150 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Koenig, E. E. Smith, V. Troiani, C. Anderson, P. Moore, and M. Grossman Medial Temporal Lobe Involvement in an Implicit Memory Task: Evidence of Collaborating Implicit and Explicit Memory Systems from fMRI and Alzheimer's Disease Cereb Cortex, April 9, 2008; (2008) bhn043v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Jack Jr, V. J. Lowe, M. L. Senjem, S. D. Weigand, B. J. Kemp, M. M. Shiung, D. S. Knopman, B. F. Boeve, W. E. Klunk, C. A. Mathis, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment Brain, March 1, 2008; 131(3): 665 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bentley, J. Driver, and R. J. Dolan Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health Brain, February 1, 2008; 131(2): 409 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.D. Rabinovici, W.W. Seeley, E.J. Kim, M.L. Gorno-Tempini, K. Rascovsky, T.A. Pagliaro, S.C. Allison, C. Halabi, J.H. Kramer, J.K. Johnson, et al. Distinct MRI Atrophy Patterns in Autopsy-Proven Alzheimer's Disease and Frontotemporal Lobar Degeneration American Journal of Alzheimer's Disease and Other Dementias, January 1, 2008; 22(6): 474 - 488. [Abstract] [PDF] |
||||
![]() |
L. L. Beason-Held, A. Moghekar, A. B. Zonderman, M. A. Kraut, and S. M. Resnick Longitudinal Changes in Cerebral Blood Flow in the Older Hypertensive Brain Stroke, June 1, 2007; 38(6): 1766 - 1773. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Rabinovici, A. J. Furst, J. P. O'Neil, C. A. Racine, E. C. Mormino, S. L. Baker, S. Chetty, P. Patel, T. A. Pagliaro, W. E. Klunk, et al. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration Neurology, April 10, 2007; 68(15): 1205 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ng, V. L. Villemagne, S. Berlangieri, S.-T. Lee, M. Cherk, S. J. Gong, U. Ackermann, T. Saunder, H. Tochon-Danguy, G. Jones, et al. Visual Assessment Versus Quantitative Assessment of 11C-PIB PET and 18F-FDG PET for Detection of Alzheimer's Disease J. Nucl. Med., April 1, 2007; 48(4): 547 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kudo, N. Okamura, S. Furumoto, M. Tashiro, K. Furukawa, M. Maruyama, M. Itoh, R. Iwata, K. Yanai, and H. Arai 2-(2-[2-Dimethylaminothiazol-5-yl]Ethenyl)-6- (2-[Fluoro]Ethoxy)Benzoxazole: A Novel PET Agent for In Vivo Detection of Dense Amyloid Plaques in Alzheimer's Disease Patients J. Nucl. Med., April 1, 2007; 48(4): 553 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Forman, E. J. Mufson, S. Leurgans, D. Pratico, S. Joyce, S. Leight, V. M.-Y. Lee, and J. Q. Trojanowski Cortical biochemistry in MCI and Alzheimer disease: Lack of correlation with clinical diagnosis Neurology, March 6, 2007; 68(10): 757 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Golob, R. Irimajiri, and A. Starr Auditory cortical activity in amnestic mild cognitive impairment: relationship to subtype and conversion to dementia Brain, March 1, 2007; 130(3): 740 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Csernansky, H. Dong, A. M. Fagan, L. Wang, C. Xiong, D. M. Holtzman, and J. C. Morris Plasma Cortisol and Progression of Dementia in Subjects With Alzheimer-Type Dementia Am J Psychiatry, December 1, 2006; 163(12): 2164 - 2169. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mapstone, D. Logan, and C. J. Duffy Cue integration for the perception and control of self-movement in ageing and Alzheimer's disease. Brain, November 1, 2006; 129(Pt 11): 2931 - 2944. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Apostolova, I. D. Dinov, R. A. Dutton, K. M. Hayashi, A. W. Toga, J. L. Cummings, and P. M. Thompson 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease Brain, November 1, 2006; 129(11): 2867 - 2873. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Reynolds, J. F. Reyes, Y. Fu, E. H. Bigio, A. L. Guillozet-Bongaarts, R. W. Berry, and L. I. Binder Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies. J. Neurosci., October 18, 2006; 26(42): 10636 - 10645. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ramani, J. H. Jensen, and J. A. Helpern Quantitative MR Imaging in Alzheimer Disease Radiology, October 1, 2006; 241(1): 26 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Apostolova, R. A. Dutton, I. D. Dinov, K. M. Hayashi, A. W. Toga, J. L. Cummings, and P. M. Thompson Conversion of Mild Cognitive Impairment to Alzheimer Disease Predicted by Hippocampal Atrophy Maps Arch Neurol, May 1, 2006; 63(5): 693 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Spires, J. D. Orne, K. SantaCruz, R. Pitstick, G. A. Carlson, K. H. Ashe, and B. T. Hyman Region-specific Dissociation of Neuronal Loss and Neurofibrillary Pathology in a Mouse Model of Tauopathy Am. J. Pathol., May 1, 2006; 168(5): 1598 - 1607. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Thal, E. Capetillo-Zarate, K. Del Tredici, and H. Braak The Development of Amyloid beta Protein Deposits in the Aged Brain Sci. Aging Knowl. Environ., March 8, 2006; 2006(6): re1 - re1. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Holtzer, M. C. Irizarry, J. Sanders, B. T. Hyman, D. J. Wegesin, A. Riba, J. Brandt, M. Albert, and Y. Stern Relation of Quantitative Indexes of Concurrent {alpha}-Synuclein Abnormalities to Clinical Outcome in Autopsy-Proven Alzheimer Disease Arch Neurol, February 1, 2006; 63(2): 226 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Perez, O. Lazarov, J. B. Koprich, E.-Y. Chen, V. Rodriguez-Menendez, J. W. Lipton, S. S. Sisodia, and E. J. Mufson Nigrostriatal Dysfunction in Familial Alzheimer's Disease-Linked APPswe/PS1{Delta}E9 Transgenic Mice J. Neurosci., November 2, 2005; 25(44): 10220 - 10229. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Francis Neuroanatomy/pathology and the interplay of neurotransmitters in moderate to severe Alzheimer disease Neurology, September 27, 2005; 65(6_suppl_3): S5 - S9. [Full Text] |
||||
![]() |
D. Mungas, D. Harvey, B. R. Reed, W. J. Jagust, C. DeCarli, L. Beckett, W. J. Mack, J. H. Kramer, M. W. Weiner, N. Schuff, et al. Longitudinal volumetric MRI change and rate of cognitive decline Neurology, August 23, 2005; 65(4): 565 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Dannhauser, Z. Walker, T. Stevens, L. Lee, M. Seal, and S. S. Shergill The functional anatomy of divided attention in amnestic mild cognitive impairment Brain, June 1, 2005; 128(6): 1418 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Golby, G. Silverberg, E. Race, S. Gabrieli, J. O'Shea, K. Knierim, G. Stebbins, and J. Gabrieli Memory encoding in Alzheimer's disease: an fMRI study of explicit and implicit memory Brain, April 1, 2005; 128(4): 773 - 787. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P.L.G. Verhoeff, A. A. Wilson, S. Takeshita, L. Trop, D. Hussey, K. Singh, H. F. Kung, M.-P. Kung, and S. Houle In-Vivo Imaging of Alzheimer Disease {beta}-Amyloid With [11C]SB-13 PET Am J Geriatr Psychiatry, December 1, 2004; 12(6): 584 - 595. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Koliatsos, T. M. Dawson, A. Kecojevic, Y. Zhou, Y.-F. Wang, and K.-X. Huang Cortical interneurons become activated by deafferentation and instruct the apoptosis of pyramidal neurons PNAS, September 28, 2004; 101(39): 14264 - 14269. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Thal, K. Del Tredici, and H. Braak Neurodegeneration in Normal Brain Aging and Disease Sci. Aging Knowl. Environ., June 9, 2004; 2004(23): pe26 - pe26. [Abstract] [Full Text] |
||||
![]() |
N. Nishioka and S. E. Arnold Evidence for Oxidative DNA Damage in the Hippocampus of Elderly Patients With Chronic Schizophrenia Am J Geriatr Psychiatry, April 1, 2004; 12(2): 167 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T. Wong, D. Manfra, F. M. Poulet, Q. Zhang, H. Josien, T. Bara, L. Engstrom, M. Pinzon-Ortiz, J. S. Fine, H.-J. J. Lee, et al. Chronic Treatment with the {gamma}-Secretase Inhibitor LY-411,575 Inhibits {beta}-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell Differentiation J. Biol. Chem., March 26, 2004; 279(13): 12876 - 12882. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ingelsson, H. Fukumoto, K. L. Newell, J. H. Growdon, E. T. Hedley-Whyte, M. P. Frosch, M. S. Albert, B. T. Hyman, and M. C. Irizarry Early A{beta} accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain Neurology, March 23, 2004; 62(6): 925 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Grossman, C. McMillan, P. Moore, L. Ding, G. Glosser, M. Work, and J. Gee What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration Brain, March 1, 2004; 127(3): 628 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Miller, M. Hosakere, A. R. Barker, C. E. Priebe, N. Lee, J. T. Ratnanather, L. Wang, M. Gado, J. C. Morris, and J. G. Csernansky Labeled cortical mantle distance maps of the cingulate quantify differences between dementia of the Alzheimer type and healthy aging PNAS, December 9, 2003; 100(25): 15172 - 15177. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Mousseau, S. Chapelsky, G. De Crescenzo, M. D. Kirkitadze, J. Magoon, S. Inoue, D. B. Teplow, and M. D. O'Connor-McCourt A Direct Interaction between Transforming Growth Factor (TGF)-{beta}s and Amyloid-{beta} Protein Affects Fibrillogenesis in a TGF-{beta}Receptor-independent Manner J. Biol. Chem., October 3, 2003; 278(40): 38715 - 38722. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Falke, J. Nissanov, T. W. Mitchell, D. A. Bennett, J. Q. Trojanowski, and S. E. Arnold Subicular Dendritic Arborization in Alzheimer's Disease Correlates with Neurofibrillary Tangle Density Am. J. Pathol., October 1, 2003; 163(4): 1615 - 1621. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yang, E. J. Mufson, and K. Herrup Neuronal Cell Death Is Preceded by Cell Cycle Events at All Stages of Alzheimer's Disease J. Neurosci., April 1, 2003; 23(7): 2557 - 2563. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Clark and J. H.T. Karlawish Alzheimer Disease: Current Concepts and Emerging Diagnostic and Therapeutic Strategies Ann Intern Med, March 4, 2003; 138(5): 400 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Scarmeas, E. Zarahn, K. E. Anderson, C. G. Habeck, J. Hilton, J. Flynn, K. S. Marder, K. L. Bell, H. A. Sackeim, R. L. Van Heertum, et al. Association of Life Activities With Cerebral Blood Flow in Alzheimer Disease: Implications for the Cognitive Reserve Hypothesis Arch Neurol, March 1, 2003; 60(3): 359 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Grossman, P. Koenig, G. Glosser, C. DeVita, P. Moore, J. Rhee, J. Detre, D. Alsop, and J. Gee Neural basis for semantic memory difficulty in Alzheimer's disease: an fMRI study Brain, February 1, 2003; 126(2): 292 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Thompson, K. M. Hayashi, G. de Zubicaray, A. L. Janke, S. E. Rose, J. Semple, D. Herman, M. S. Hong, S. S. Dittmer, D. M. Doddrell, et al. Dynamics of Gray Matter Loss in Alzheimer's Disease J. Neurosci., February 1, 2003; 23(3): 994 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Sheng, D. L. Price, and V. E. Koliatsos Disruption of Corticocortical Connections Ameliorates Amyloid Burden in Terminal Fields in a Transgenic Model of Abeta Amyloidosis J. Neurosci., November 15, 2002; 22(22): 9794 - 9799. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fukumoto, B. S. Cheung, B. T. Hyman, and M. C. Irizarry {beta}-Secretase Protein and Activity Are Increased in the Neocortex in Alzheimer Disease Arch Neurol, September 1, 2002; 59(9): 1381 - 1389. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Y. HWANG, K. R. CHAE, T. S. KANG, J. H. HWANG, C. H. LIM, H. K. KANG, J. S. GOO, M. R. LEE, H. J. LIM, S. H. MIN, et al. Alterations in behavior, amyloid {beta}-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease FASEB J, June 1, 2002; 16(8): 805 - 813. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Cummings and G. Cole Alzheimer Disease JAMA, May 8, 2002; 287(18): 2335 - 2338. [Full Text] [PDF] |
||||
![]() |
T. Ohnishi, H. Matsuda, T. Tabira, T. Asada, and M. Uno Changes in Brain Morphology in Alzheimer Disease and Normal Aging: Is Alzheimer Disease an Exaggerated Aging Process? AJNR Am. J. Neuroradiol., October 1, 2001; 22(9): 1680 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Deng, M. C. Irizarry, R. M. Nitsch, J. H. Growdon, and G. W. Rebeck Elevation of Cystatin C in Susceptible Neurons in Alzheimer's Disease Am. J. Pathol., September 1, 2001; 159(3): 1061 - 1068. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gotz, F. Chen, J. van Dorpe, and R. M. Nitsch Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Abeta 42 Fibrils Science, August 24, 2001; 293(5534): 1491 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Fein, V. Di Sclafani, J. Tanabe, V. Cardenas, M. W. Weiner, W. J. Jagust, B. R. Reed, D. Norman, N. Schuff, L. Kusdra, et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease Neurology, December 12, 2000; 55(11): 1626 - 1635. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Csernansky, L. Wang, S. Joshi, J. P. Miller, M. Gado, D. Kido, D. McKeel, J. C. Morris, and M. I. Miller Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus Neurology, December 12, 2000; 55(11): 1636 - 1643. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Mitchell, J. Nissanov, L.-Y. Han, E. J. Mufson, J. A. Schneider, E. J. Cochran, D. A. Bennett, V. M.-Y. Lee, J. Q. Trojanowski, and S. E. Arnold Novel Method to Quantify Neuropil Threads in Brains from Elders With or Without Cognitive Impairment J. Histochem. Cytochem., December 1, 2000; 48(12): 1627 - 1638. [Abstract] [Full Text] |
||||
![]() |
I. Greeve, I. Hermans-Borgmeyer, C. Brellinger, D. Kasper, T. Gomez-Isla, C. Behl, B. Levkau, and R. M. Nitsch The Human DIMINUTO/DWARF1 Homolog Seladin-1 Confers Resistance to Alzheimer's Disease-Associated Neurodegeneration and Oxidative Stress J. Neurosci., October 1, 2000; 20(19): 7345 - 7352. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Jack Jr., R. C. Petersen, Y. Xu, P. C. O'Brien, G. E. Smith, R. J. Ivnik, B. F. Boeve, E. G. Tangalos, and E. Kokmen Rates of hippocampal atrophy correlate with change in clinical status in aging and AD Neurology, August 22, 2000; 55(4): 484 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Van Hoesen, J. Parvizi, and C.-C. Chu Orbitofrontal Cortex Pathology in Alzheimer's Disease Cereb Cortex, March 1, 2000; 10(3): 243 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
|






















